SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Hoechst (HOE) -- Ignore unavailable to you. Want to Upgrade?


To: Mike McFarland who wrote (29)10/30/1998 12:57:00 PM
From: Mike McFarland  Respond to of 42
 
Vertex and Hoechst Marion Roussel Announce Start of Clinical Trial with HMR 3480/VX-740, a Novel Compound for Treatment of Inflammatory
Diseases


biz.yahoo.com



To: Mike McFarland who wrote (29)11/17/1998 7:12:00 AM
From: Henry Niman  Read Replies (1) | Respond to of 42
 
Several news sources are focusing on the HOE/RP merger and HOE split-up of units. Details on the above as well as AHP/MTC deal are linked to the Merger Mania table at biocognizance.com
(Mirrored site at webf2179.ntx.net may be faster)